Related Experiment Video
Updated: Oct 13, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
[Current status of hyperkalemia in dialysis patients in China]
1Department of Nephrology, the First Affiliated Hospital of Sun Yat-sen University/Key Laboratory of Nephrology, National Health Commission/Guangdong Provincial Key Laboratory of Nephrology, Guangzhou 510080, China.
Insights
Hyperkalemia affects 20.7% of dialysis patients, with hemodialysis and diabetes mellitus being key risk factors. Understanding these associations is crucial for managing electrolyte balance in kidney disease patients.
Area of Science:
- Nephrology
- Internal Medicine
- Clinical Research
Background:
- Hyperkalemia is a common and serious complication in patients with end-stage renal disease requiring dialysis.
- Identifying the prevalence and associated factors of hyperkalemia is essential for improving patient outcomes and guiding clinical management.
- Dialysis modalities, including hemodialysis (HD) and peritoneal dialysis (PD), may influence electrolyte balance and hyperkalemia risk.
Purpose of the Study:
- To determine the prevalence of hyperkalemia among patients undergoing maintenance hemodialysis and peritoneal dialysis.
- To investigate the clinical and biochemical factors associated with the occurrence of hyperkalemia in this patient population.
Main Methods:
- A multi-center study included 12,364 patients (aged ≥18 years, dialysis duration ≥3 months) from January 2017 to December 2019.
- Data on patient demographics, dialysis modality (HD or PD), comorbidities, and laboratory values were collected.
- Multivariate logistic regression analysis was employed to identify factors associated with hyperkalemia.
Main Results:
- The overall prevalence of hyperkalemia was 20.7% (2,554/12,364 patients).
- Factors significantly associated with hyperkalemia included hemodialysis (OR=2.25), diabetes mellitus (OR=1.65), high BMI (OR=1.06), elevated serum albumin (OR=1.04) and phosphorus (OR=3.12).
- Low serum bicarbonate (OR=0.89), triglycerides (OR=0.76), and creatinine (OR=0.95), along with the use of ACE inhibitors/ARBs (OR=1.38) and beta-blockers (OR=1.32), were also linked to hyperkalemia.
Conclusions:
- Hyperkalemia is prevalent in 20.7% of dialysis patients, highlighting a significant clinical challenge.
- Hemodialysis, diabetes mellitus, higher BMI, elevated serum albumin and phosphorus are associated with increased hyperkalemia risk.
- Lower serum bicarbonate, triglycerides, creatinine, and use of ACEI/ARBs are also linked to hyperkalemia, necessitating careful monitoring and management.
Abstract:
Objective: To investigate the prevalence and associated factors of hyperkalemia in dialysis patients. Methods: Patients underwent hemodialysis (HD) and peritoneal dialysis (PD) from multi-center databases were recruited from January 2017 to December 2019, and those aged ≥18 years and with dialysis duration ≥3 months were included to analyze the prevalence and related factors of hyperkalemia. Results: A total of 12 364 patients were enrolled in the study, and 6 836 cases were men. The average age of the patients was (51±15) years. Among these patients, 4 230 cases underwent HD while 8 134 received PD. Hyperkalemia was detected in 20.7% (2 554/12 364) of the patients while hypokalemia was found in 17.0%(2 102/12 364) of the patients. Multivariate logistic regression showed that HD (OR=2.25, 95%CI: 1.54-3.30), diabetes mellitus (DM) (OR=1.65, 95%CI: 1.17-2.32), high body mass index (BMI) (OR=1.06, 95%CI: 1.03-1.09), high levels of serum albumin (OR=1.04, 95%CI: 1.01-1.07) and phosphorus (OR=3.12, 95%CI: 2.44-4.00), low levels of serum bicarbonate (OR=0.89, 95%CI: 0.87-0.92), triglycerides (OR=0.76, 95%CI: 0.68-0.85) and creatinine (OR=0.95, 95%CI: 0.90-0.99), usage of angiotensin converting enzyme inhibitor/Angiotensin Ⅱ receptor antagonist (ACEI/ARB, OR=1.38, 95%CI: 1.11-1.72) and beta-blocker (OR=1.32, 95%CI: 1.07-1.64) were associated with hyperkalemia. Conclusions: Hyperkalemia occurred in 20.7% of the dialysis patients. HD, DM, high BMI, high levels of serum albumin and phosphorus, low levels of serum bicarbonate, triglycerides and creatinine, use of ACEI/ARB were associated with hyperkalemia.
Related Concept Videos
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Chronic Kidney Disease IV: Nursing Management

